Raymond James Financial Services Advisors, Inc. Bluebird Bio, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 28,710 shares of BLUE stock, worth $204,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,710
Previous 27,710
3.61%
Holding current value
$204,415
Previous $27,000
48.15%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BLUE
# of Institutions
19Shares Held
20.3MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$110 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$33.2 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$298,6270.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$225,2340.59% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ14.2KShares$101,1390.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $549M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...